Navigation Links
Life Sciences & Health Care Companies Unprepared for Information Security Risks: Deloitte Survey
Date:7/22/2009

st a backdrop of reduced spending, staff cuts and organizational changes," said Amry Junaideen, Health Sciences & Government leader -- Security & Privacy, Deloitte.

"And based on the results of our study, the industry is not yet prepared to meet the risk management challenges as we head into a period of massive opportunity to maximize the value of data and the promise of new automation. This may be because the industry is behind in implementing important foundational technologies, such as identity and access management solutions, or reluctance to adequately fund the security functions. Bottom line: the industry needs to act aggressively to catch up," Junaideen added.

Despite more than 50 percent of respondents across sectors reporting their information security budgets increased, the majority of increases were in the low range of 1 to 15 percent. Moreover, respondents confirmed that information security budgets are not separate from the IT budget, and most IT budgets dedicated just 1 to 3 percent to information security.

"The problem with folding information security into the overall IT budget," said Junaideen, "is that security often falls to the bottom of the funding list. Priority is given to projects and infrastructure that are perceived as being more important to the business or contributing to revenue generation."

In examining areas such as governance, and in particular the information security function and the role of the Chief Information Security Officer (CISO), respondents revealed a glaring weakness. While the majority of respondents across all regions indicated they indeed have a CISO and this role is taking on greater significance with respect to planning, governance, administration, architecture and IT risk management, 43 percent of respondents do not have a CISO.

"This is a disturbing statistic," said Junaideen, "especially since a strong
'/>"/>

SOURCE Deloitte
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Labs Are Vital(TM) Announces Winners of 2009 National Video Contest to Highlight Careers in Lab Sciences
2. Reminder - Human Genome Sciences to Host Conference Call to Discuss Top-Line Phase 3 Results for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Systemic Lupus Erythematosus
3. China Medicine Receives rADTZ Feasibility Report from the Feed Research Institute, Chinese Academy of Agricultural Sciences
4. Roush Life Sciences Taylor to Chair MassMEDIC
5. Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences(R) to Provide World-Class Fluid Management and Liquid/Powder System Solutions
6. Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
7. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
8. Scientists Gather to Discuss Novel Uses of Caliper Life Sciences Discovery Platforms and Technology
9. Derma Sciences Announces First Commercial Sales of BIOGUARD(TM) Barrier Dressings
10. Microsoft Announces Winners of the 2009 Pharmaceutical and Life Sciences Innovation Awards
11. Horse Study: RBC Life Sciences Antioxidant, Microhydrin, Reduced Lactic Acid Buildup and Improved Hydration During Strenuous Exercise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Biocide Systems is ... Wrench Advisors as a consultant and partner for ... accounts. , As Wrench Advisors explains on its ... your organization plan and execute programs by leveraging ... channels. Our experience developing joint venture partnerships and ...
(Date:8/20/2014)... 2014 In its latest blog post, ... program that gets clients off to a great start and ... in, is highlighting an important and possibly life-changing – perhaps ... who wants to understand the insidious nature of drug abuse: ... that drug abuse targets a certain socioeconomic group, such as ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The award-winning ... (ACPS), has expanded its presence throughout Houston to a ... Eye Institute and Laser Center building. ACPS plastic surgeon ... step forward for ACPS, which has risen to become ... surgery practices in the state since its establishment in ...
(Date:8/20/2014)... August 20, 2014 Texas Medical Research Associates ... The study will help test the effectiveness of a new ... high cholesterol may be eligible to participate in the study. ... in the blood can lead to cardiovascular disease, the no. ... can help reduce the risk of heart disease and stroke. ...
(Date:8/20/2014)... -- White, straight women are much more likely to ... women, a new study finds. Researchers examined data ... 44, who took part in polls in 2002 and ... Family Growth study. In the first poll, 13 ... for infertility. This ranged from getting advice from doctors ...
Breaking Medicine News(10 mins):Health News:Biocide Systems Announces Partnership with Wrench Advisors 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 3Health News:Aesthetic Center for Plastic Surgery Expands Its Reach in Texas 2Health News:Texas Medical Research Associates Announce New Study 2Health News:White Women More Likely to Seek Fertility Treatment: Report 2
... , TUESDAY, April 17 (HealthDay News) -- A group of ... indicators of your chances of living to age 70 than ... challenge the long-held belief that race or the region of ... how long you may live, according to researchers from Stanford ...
... The increasing globalization of the drug supply ... and diversion of medicines, growth of illegal Internet ... into the supply chain. As pharmaceutical companies, regulatory ... determine the best approaches to securing increasingly complex ...
... Randy Dotinga HealthDay Reporter , TUESDAY, April 17 ... value of proton therapy, an expensive new kind of radiation ... the treatment instead of the standard radiation therapy were more ... There also did not appear to be any extra benefit ...
... SEATTLE Larry Corey, M.D., president and director of Fred ... the American Academy of Arts and Sciences, one of the ... centers. , "I,m extremely honored to be in the same ... science, medicine and the arts," Corey said. "I,m also very ...
... April 17 (HealthDay News) -- New research adds to the ... plaques, the brain-clogging fragments that have been associated with Alzheimer,s ... Berlin, researchers report that they were able to use a ... brains of patients whose Alzheimer,s was confirmed after death. ...
... In an analysis of three different types ... cancer, compared with conformal radiation therapy, intensity-modulated radiation ... gastrointestinal adverse effects, hip fractures, and receipt of ... proton therapy was associated with more gastrointestinal adverse ...
Cached Medicine News:Health News:Social Factors May Affect Lifespan More Than Race, Location 2Health News:Global, common approach to pharmaceutical supply chain integrity the focus of workshop 2Health News:Global, common approach to pharmaceutical supply chain integrity the focus of workshop 3Health News:Study Casts Doubt on Value of Pricey Prostate Cancer Therapy 2Health News:Study Casts Doubt on Value of Pricey Prostate Cancer Therapy 3Health News:Hutchinson Center president elected to American Academy of Art and Sciences 2Health News:Hutchinson Center president elected to American Academy of Art and Sciences 3Health News:New Method to Reveal Alzheimer's Marker Shows Promise 2Health News:Study examines adverse effects among different radiation therapies for prostate cancer 2Health News:Study examines adverse effects among different radiation therapies for prostate cancer 3
(Date:8/20/2014)... , August 20, 2014 ... Conducted in the US  KalVista Pharmaceuticals ("KalVista"), ... edema (DME), today announces that it has begun a ... plasma kallikrein inhibitor, KVD001, for the treatment of DME. ... of the Beetham Eye Institute, Joslin Diabetes Center; Harvard ...
(Date:8/19/2014)...  The Alabama Supreme Court, in a 6-3 decision on ... who mislead doctors into believing that prescription medicines the companies ... v. Wyeth, and the decision came after the Supreme Court ... year. Heninger Garrison Davis attorneys Lew Garrison and ... Danny Weeks . The decision won a ...
(Date:8/19/2014)... , Aug. 19, 2014  Northwest Biotherapeutics (NASDAQ: ... DCVax® personalized immune therapies for solid tumor cancers, announced ... last Thursday, August 14, 2014, has closed.  The three-year ... at $7.30 per share of common stock.  The investors ... purchase up to an additional 30% of these notes ...
Breaking Medicine Technology:KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 2NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 3
... Epiphany Biosciences announced,today, the initiation of a ... treatment and management of acute infectious,mononucleosis. Currently, there ... debilitating condition or any other disease caused by,the ... broad spectrum of anti-viral activity,including inhibition of viral ...
... SAN FRANCISCO, Calif., Dec. 6 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... (NYSE: PFE ), has begun a Phase 1 ... syk kinase inhibitor, R343,for the treatment of allergic asthma. ... Under the terms of the companies, 2005 collaboration ...
Cached Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3
... 1100RS Spectrophotometers are simple, ... for use in many ... educational, clinical, industrial and ... COD vial holders, Windows ...
Spectra 2000 Digital Spectrophotometer is designed for quantitative and qualitative analysis in visible range from 320 nm to 1020 nm....
... Series Spectrophotometer is truly ... UV-VIS instrumentation. The latest ... into a radically new ... and performance unprecedented in ...
... Darkfield Quebec Colony Counter allows the user ... choice of models allows for digital counting or ... over the standard lens increasing magnification to 3.0X. ... lens to be raised or lowered. The lens ...
Medicine Products: